Leukocare (Group)

Leukocare AG, located in Martinsried/Munich, Germany, is a biotechnology company specialized in the field of biopharmaceutical formulation development. Operating at the interface of drug substance and drug product development, Leukocare combines sound knowledge of formulation development with bioinformatics and artificial intelligence. The formulation development approach consists of two elements: a library of up to 100 different regulatory well-established and employed excipients and a rational development approach which employs statistical software and self-learning algorithms as well as state of the art design of experiment (DoE) matrices. By utilizing the artificial intelligence elements, Leukocare is able to specifically combine excipients leading to stabilizing formulations tailored to the drug product’s needs. Leukocare’s superior and innovative drug product formulations can be applied to a broad range of applications: biologics & biosimilars, vaccines & viral vectors and biofunctionalized devices. *

	Start	2003-01-01 splitoff
	Today	Leukocare AG
	Predecessor	University of Frankfurt (Goethe-Universität)
	Industry	BIOTECH
	Industry 2	Stabilizing and Protecting Solutions (SPS®) technology
	Person	Scholl, Michael (Leukocare AG 201105 CEO)
	Person 2	Dönges, Georg (Leukocare 202106 CFO)

	Region	Martinsried
	Country	Germany
	City	n. a.
		Address record changed: 2021-06-23

Basic data	Employees	B: 11 to 50 (2017-09-14)

		* Document for »About Section«: Leukocare AG. (3/24/21). "Press Release: Leukocare and Formycon Cooperate in the Development of High-quality Biopharmaceuticals". Martinsried.

		Record changed: 2025-03-16